Literature DB >> 15766660

RalGDS is required for tumor formation in a model of skin carcinogenesis.

Ana González-García1, Catrin A Pritchard, Hugh F Paterson, Georgia Mavria, Gordon Stamp, Christopher J Marshall.   

Abstract

To investigate the role of signaling by the small GTPase Ral, we have generated mice deficient for RalGDS, a guanine nucleotide exchange factor that activates Ral. We show that RalGDS is dispensable for mouse development but plays a substantial role in Ras-induced oncogenesis. Lack of RalGDS results in reduced tumor incidence, size, and progression to malignancy in multistage skin carcinogenesis, and reduced transformation by Ras in tissue culture. RalGDS does not appear to participate in the regulation of cell proliferation, but instead controls survival of transformed cells. Experiments performed in cells isolated from skin tumors suggest that RalGDS mediates cell survival through the activation of the JNK/SAPK pathway. These studies identify RalGDS as a key component in Ras-dependent carcinogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766660     DOI: 10.1016/j.ccr.2005.01.029

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  66 in total

1.  A big new job for small GTPases.

Authors:  Ana Carmena
Journal:  Small GTPases       Date:  2012-05-31

Review 2.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

3.  Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization.

Authors:  Dimitrios Koutsimpelas; Uwe Felmeden; Wolf J Mann; Jürgen Brieger
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

4.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

5.  RalGDS couples growth factor signaling to Akt activation.

Authors:  Yansheng Hao; Richard Wong; Larry A Feig
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

6.  R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes.

Authors:  Akiyuki Takaya; Takahiro Kamio; Michitaka Masuda; Naoki Mochizuki; Hirofumi Sawa; Mami Sato; Kazuo Nagashima; Akiko Mizutani; Akira Matsuno; Etsuko Kiyokawa; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2007-03-07       Impact factor: 4.138

7.  RalA functions as an indispensable signal mediator for the nutrient-sensing system.

Authors:  Tomohiko Maehama; Masahiko Tanaka; Hiroshi Nishina; Makoto Murakami; Yasunori Kanaho; Kentaro Hanada
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

8.  KRAS and YAP1 converge to regulate EMT and tumor survival.

Authors:  Diane D Shao; Wen Xue; Elsa B Krall; Arjun Bhutkar; Federica Piccioni; Xiaoxing Wang; Anna C Schinzel; Sabina Sood; Joseph Rosenbluh; Jong W Kim; Yaara Zwang; Thomas M Roberts; David E Root; Tyler Jacks; William C Hahn
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

9.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

Review 10.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.